Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
LFWD Stock Forecast 2026-2027
$6.68
Current Price
$25.28M
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to LFWD Price Targets
+349.1%
To High Target of $30.00
+199.4%
To Median Target of $20.00
+49.7%
To Low Target of $10.00
LFWD Price Momentum
+1.7%
1 Week Change
-11.6%
1 Month Change
-60.8%
1 Year Change
-3.5%
Year-to-Date Change
-64.1%
From 52W High of $18.60
+61.4%
From 52W Low of $4.14
📊 TOP ANALYST CALLS
Did LFWD Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if ReWalk Robotics is one of their latest high-conviction picks.
Latest LFWD Stock Price Targets & Analyst Predictions
Based on our analysis of 4 Wall Street analysts, LFWD has a bullish consensus with a median price target of $20.00 (ranging from $10.00 to $30.00). The overall analyst rating is Strong Buy (9.0/10). Currently trading at $6.68, the median forecast implies a 199.4% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Swayampakula Ramakanth at HC Wainwright & Co., suggesting a 49.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
LFWD Analyst Ratings
2
Buy
0
Hold
0
Sell
LFWD Price Target Range
Low
$10.00
Average
$20.00
High
$30.00
Current: $6.68
Latest LFWD Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for LFWD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 19, 2026 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Maintains | $10.00 |
| Nov 18, 2025 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Maintains | $4.50 |
| Mar 11, 2025 | Lake Street | Ben Haynor | Buy | Maintains | $4.00 |
| Mar 11, 2025 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $13.00 |
| Feb 20, 2025 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $13.00 |
| Feb 20, 2025 | Lake Street | Ben Haynor | Buy | Maintains | $4.50 |
| Feb 10, 2025 | Laidlaw & Co. | Yale Jen | Buy | Initiates | $10.00 |
| Nov 13, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $13.00 |
| Aug 16, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Maintains | $13.00 |
| May 16, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Maintains | $13.00 |
| Apr 15, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $9.00 |
| Feb 28, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $3.00 |
| Nov 15, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Aug 14, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Aug 10, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Jul 3, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| May 12, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Feb 24, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Nov 15, 2022 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Aug 10, 2022 | HC Wainwright & Co. | Buy | Maintains | $N/A |
Lifeward Ltd. (LFWD) Competitors
The following stocks are similar to ReWalk Robotics based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Lifeward Ltd. (LFWD) Financial Data
Lifeward Ltd. has a market capitalization of $25.28M with a P/E ratio of -0.4x. The company generates $22.03M in trailing twelve-month revenue with a -90.4% profit margin.
Revenue growth is -32.7% quarter-over-quarter, while maintaining an operating margin of -112.7% and return on equity of -146.1%.
Valuation Metrics
Market Cap
$25.28M
Enterprise Value
$12.35M
P/E Ratio
-0.4x
PEG Ratio
0.0x
Price/Sales
1.1x
Growth & Margins
Revenue Growth (YoY)
-32.7%
Gross Margin
+21.4%
Operating Margin
-112.7%
Net Margin
-90.4%
EPS Growth
-32.7%
Financial Health
Cash/Price Ratio
+21.2%
Current Ratio
1.3x
Debt/Equity
52.2x
ROE
-146.1%
ROA
-41.0%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Lifeward Ltd. (LFWD) Business Model
About Lifeward Ltd.
What They Do
Provides innovative healthcare solutions and devices.
Business Model
Lifeward Ltd. generates revenue by developing, producing, and distributing medical devices and health management systems. It serves a variety of sectors, including hospitals, clinics, and home healthcare, offering a diverse range of products that enhance patient care through advanced technology.
Additional Information
The company plays a significant role in the medical technology industry, focusing on patient monitoring and management. Lifeward Ltd. emphasizes continuous innovation and quality, contributing to improved healthcare delivery and patient outcomes.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
81
CEO
Mr. William Mark Grant
Country
Israel
IPO Year
2014
Website
golifeward.comLifeward Ltd. (LFWD) Latest News & Analysis
Latest News
Quick Summary
Lifeward Ltd. announced a development in Hudson, Mass., and Yokneam Illit, Israel, on March 25, 2026. Further details were not provided in the excerpt.
Why It Matters
The mention of Lifeward Ltd. potentially indicates developments in biotech or healthcare, sectors that can significantly impact market trends and investment opportunities.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Lifeward Ltd. (LFWD) held its Q4 2025 earnings call, detailing financial performance and company updates. Further specifics on earnings and projections were discussed during the call.
Why It Matters
The Lifeward Ltd. Q4 2025 earnings call provides insights into financial performance, future guidance, and market positioning, which can influence investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Lifeward Ltd. gains shareholder approval for a strategic transaction, advancing its transformation into a diversified biomedical company with new oral protein delivery technology and improved efficiency.
Why It Matters
Oramed's strategic transaction approval and Lifeward's new technology platform signal growth potential and improved cash flow, enhancing investor confidence in future performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Lifeward Ltd. is positioning itself as a diversified biomedical innovation company, integrating Oramed's oral delivery tech, gaining access to $47 million for clinical development.
Why It Matters
Lifeward's acquisition of Oramed's technology enhances its market position and profitability potential, while access to $47 million boosts growth prospects, positively impacting investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
1 month ago
Quick Summary
Lifeward Ltd. (Nasdaq: LFWD) will release its Q4 and full year 2025 financial results on March 18, 2026, before market opening.
Why It Matters
Lifeward's upcoming financial results can impact stock performance, revealing growth potential or challenges, influencing investment decisions and market perception of the company’s future.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Lifeward Ltd. announced developments on March 11, 2026, in Hudson, Mass., and Yokneam Illit, Israel. Further details were not provided in the excerpt.
Why It Matters
Lifeward Ltd.'s announcement may indicate developments in their products or partnerships, potentially impacting stock performance and market positioning.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About LFWD Stock
What is Lifeward Ltd.'s (LFWD) stock forecast for 2026?
Based on our analysis of 4 Wall Street analysts, Lifeward Ltd. (LFWD) has a median price target of $20.00. The highest price target is $30.00 and the lowest is $10.00.
Is LFWD stock a good investment in 2026?
According to current analyst ratings, LFWD has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $6.68. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for LFWD stock?
Wall Street analysts predict LFWD stock could reach $20.00 in the next 12 months. This represents a 199.4% increase from the current price of $6.68. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Lifeward Ltd.'s business model?
Lifeward Ltd. generates revenue by developing, producing, and distributing medical devices and health management systems. It serves a variety of sectors, including hospitals, clinics, and home healthcare, offering a diverse range of products that enhance patient care through advanced technology.
What is the highest forecasted price for LFWD Lifeward Ltd.?
The highest price target for LFWD is $30.00 from at , which represents a 349.1% increase from the current price of $6.68.
What is the lowest forecasted price for LFWD Lifeward Ltd.?
The lowest price target for LFWD is $10.00 from Swayampakula Ramakanth at HC Wainwright & Co., which represents a 49.7% increase from the current price of $6.68.
What is the overall LFWD consensus from analysts for Lifeward Ltd.?
The overall analyst consensus for LFWD is bullish. Out of 4 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $20.00.
How accurate are LFWD stock price projections?
Stock price projections, including those for Lifeward Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 17, 2026 7:42 AM UTC